elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30839726-F742A3FF-9F9C-4C05-A957-ACBD2C078274
Q30839726-F742A3FF-9F9C-4C05-A957-ACBD2C078274
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30839726-F742A3FF-9F9C-4C05-A957-ACBD2C078274
Quantification of frequent-hitter behavior based on historical high-throughput screening data.
P2860
Q30839726-F742A3FF-9F9C-4C05-A957-ACBD2C078274
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30839726-F742A3FF-9F9C-4C05-A957-ACBD2C078274
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e569e1c0e96b66410da1722dcf1226a65c7521ca
P2860
Life beyond kinases: structure-based discovery of sorafenib as nanomolar antagonist of 5-HT receptors.